Nvidia’s results, Tesla’s European sales, Japan trade - what’s moving markets
Investing.com - Gain Therapeutics reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Gain Therapeutics announced earnings per share of $-0.380 on revenue of $53K. Analysts polled by Investing.com EPS of $-0.449 on revenue of $64K.
Gain Therapeutics 's are down 53.92% and is trading at $3.170 , still down 67.32% from its 52 week high of $9.70 set on Monday, November 15, 2021.
Gain Therapeutics follows other major Healthcare sector earnings this month
Gain Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar